Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Forks in the road for CAR T and CAR NK cell cancer therapies
Oula K. Dagher, Avery D. Posey
Nature Immunology (2023) Vol. 24, Iss. 12, pp. 1994-2007
Closed Access | Times Cited: 47

Showing 26-50 of 47 citing articles:

Antibiotic-Free Gene Vectors: A 25-Year Journey to Clinical Trials
Corinne Marie, Daniel Scherman
Genes (2024) Vol. 15, Iss. 3, pp. 261-261
Open Access | Times Cited: 1
In situ genetic engineering of host T-cells based on acellular scaffold strategy: a big but also small step for solid tumor immunotherapy
Shuyan Han, Zixuan Zhao, Jun Wu
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Combinational delivery of TLR4 and TLR7/8 agonist enhanced the therapeutic efficacy of immune checkpoint inhibitors to colon tumor
Mengjiao Wang, Quan Wan, Chenglv Wang, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 1
Cracking the Codes behind Cancer Cells’ Immune Evasion
Nikita Mundhara, Pritam Sadhukhan
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8899-8899
Open Access | Times Cited: 1
Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era
Xin Xiong, Xin Wang, Cuicui Liu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Nanomaterial-based cancer immunotherapy: enhancing treatment strategies
Mengxiang Tian, Xionglin Liu, Haiping Pei
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 1
Universal CAR cell therapy: Challenges and expanding applications
Ziyu Wu, Yifan Wang, Xin Jin, et al.
Translational Oncology (2024) Vol. 51, pp. 102147-102147
Open Access | Times Cited: 1
Recent advances in polymeric and lipid stimuli-responsive nanocarriers for cell-based cancer immunotherapy
Alireza Gharatape, Bentolhoda Amanzadi, F. MOHAMADI, et al.
Nanomedicine (2024), pp. 1-24
Closed Access | Times Cited: 1
Natural Killer Cells in Cancers of Respiratory System and Their Applications in Therapeutic Approaches
Maryam Dokhanchi, Atefe Panahipoor Javaherdehi, Mohammad Raad, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 11
Open Access | Times Cited: 1
The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
Pin Mei Yao, Yaguang Liu, Gang Huang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastoma
Josephine G. M. Strijker, Guillem Pascual‐Pasto, Yannine J. Kalmeijer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Engineering Mesoscale T Cell Receptor Clustering by Plug‐and‐Play Nanotools
M. Florencia Sánchez, Sevi Faria, Stefan Frühschulz, et al.
Advanced Materials (2024) Vol. 36, Iss. 45
Closed Access
Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against Glioblastoma
Trang Nguyen, Qiuqiang Gao, Jeong-Yeon Mun, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1155-1155
Open Access
Therapeutic applications of cell engineering using mRNA technology
Yujia He, Angus P. R. Johnston, Colin W. Pouton
Trends in biotechnology (2024)
Closed Access
Pharmaceutical Strategies for Optimized mRNA Expression
Yingying Shi, J. Mao, Sijie Wang, et al.
Biomaterials (2024) Vol. 314, pp. 122853-122853
Closed Access
Editorial: Structure and function of the immunological and redirecting artificial synapses and their clinical implications
Manuel Izquierdo, Javier Ruiz-Navarro, Cosima T. Baldari, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
From oncolytic virotherapy to individualized multimodal immunotherapy with focus on glioblastoma
Linde F. C. Kampers, Peter Van de Vliet, Volker Schirrmacher, et al.
Elsevier eBooks (2024)
Closed Access
Optimizing the Procedure for Manufacturing Clinical-grade Genetically Manipulated NK cells for Adoptive Immunotherapy
Haolong Lin, Shanwei Ye, Shujia Zhang, et al.
Cytotherapy (2024)
Closed Access
Emerging strategies to overcome ovarian cancer: advances in immunotherapy
Tatiana Massariol Pimenta, Josiany Carlos de Souza, Bárbara da Silva Martins, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
The role of CD95 in modulating CAR T-cell therapy: Challenges and therapeutic opportunities in oncology
Asif Ahmad Bhat, Abdulmalik Saleh Alfawaz Altamimi, Ahsas Goyal, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113675-113675
Closed Access
CAR-armored-cell therapy in solid tumor treatment
Yan Liu, Lin Xiao, Man Yang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
An innovative cellular medicine approach via the utilization of novel nanotechnology-based biomechatronic platforms as a label-free biomarker for early melanoma diagnosis
Jassim A. Alqabandi, Rhiannon David, Ussama M. Abdel‐Motal, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Engineering a controllable and reversible switch for CAR-based cellular immunotherapies via a genetic code expansion system
Yue Liu, Lingna An, Xiaoqi Wang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access
Previous Page - Page 2

Scroll to top